Christof Geisen
Randomised trial of a clinical dosing algorithm to start anticoagulation with phenprocoumon
Caduff Good A, Nobel D, Krähenbühl S, Geisen C, Henz S. Randomised trial of a clinical dosing algorithm to start anticoagulation with phenprocoumon. Swiss Med Wkly 2013; 143:w13709.
08.01.2013Randomised trial of a clinical dosing algorithm to start anticoagulation with phenprocoumon
08.01.2013Swiss Med Wkly 2013; 143:w13709
Caduff Good Angela, Nobel Daniel, Krähenbühl Stephan, Geisen Christof, Henz Samuel
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect
Gispert S, Ludolph A, Riess O, Krüger R, Andersen P, Berg D, Weber M, Becker T, Gitler A, Geisen C, Liepelt I, Bauer P, Waibel S, Kurz A, Auburger G. The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 2011; 45:356-61.
25.08.2011The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect
25.08.2011Neurobiol Dis 2011; 45:356-61
Gispert Suzana, Ludolph Albert C, Riess Olaf, Krüger Rejko, Andersen Peter M, Berg Daniela, Weber Markus, Becker Tim, Gitler Aaron D, Geisen Christof, Liepelt Inga, Bauer Peter, Waibel Stefan, Kurz Alexander, Auburger Georg